Identification of Novel Antimitotic Agents Acting at the Tubulin Level by Computer-assisted Evaluation of Differential Cytotoxicity Data

Cancer Research

Volumn 52, Issue 14, 1992, Pages 3892-3900

  Hamel, Ernest ^b,e  

^a AEDC/MS 6200   (United States)

^b Laboratory of Molecular Pharmacology   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLCHICINE DERIVATIVE; DOLASTATIN; HALICHONDRIN B; MAYTANSINE; PACLITAXEL; PODOPHYLLOTOXIN DERIVATIVE; TENIPOSIDE; VINBLASTINE DERIVATIVE; VINCRISTINE;

ALGORITHM; ANTINEOPLASTIC ACTIVITY; ARTICLE; BINDING KINETICS; CANCER INHIBITION; COMPUTER ASSISTED DIAGNOSIS; CONCENTRATION RESPONSE; CYTOTOXICITY; DRUG SCREENING; HYDROLYSIS; LEUKEMIA; MICROTUBULE ASSEMBLY; MITOSIS INHIBITION; PRIORITY JOURNAL; TUMOR CELL LINE;

ALGORITHMS; ANTINEOPLASTIC AGENTS; AUTOMATIC DATA PROCESSING; DRUG SCREENING ASSAYS, ANTITUMOR; GUANOSINE TRIPHOSPHATE; HUMAN; HYDROLYSIS; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN; TUMOR CELLS, CULTURED;

EID: 0026752669     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Boyd, M. R. National Cancer Institute drug discovery and development. In: E. J. Frei and E. J. Freireich (eds.), Accomplishments in Oncology, pp. 68-76. Philadelphia: J. B. Lippincott Co., 1986.
2. Boyd, M. R. Status of the NCI preclincial antitumor drug discovery screen. In: V. T. DeVita, S. Hellman, and S. A. Rosenberg (eds.). Cancer: Principles and Practice of Oncology Updates, pp. 1-12. Philadelphia: J. B. Lippincott Co., 1989.
3. Monks, A., Scudiero, D., Skehan, P., Shoemaker, R., Paull, K., Vistica, D., Hose, C., Langley, J., Cronise, P., Vaigro-Wolff, A., Gray-Goodrich, M., Campbell, H., Mayo, J., and Boyd, M. Feasibility of a high-flux anticancer drug screen utilizing a diverse panel of human tumor cell lines in culture. J. Natl. Cancer Inst., 8S: 757-766, 1991.
4. Paull, K. D., Shoemaker, R. H., Hodes, L., Monks, A., Scudiero, D. A., Rubinstein, L., Plowman, J., and Boyd, M. R. Display and analysis of patterns of differential activity of drugs against human tumor cell lines: development of mean graph and COMPARE algorithm. J. Natl. Cancer Inst., 81: 1088-1092, 1989.
5. Hamel, E., and Lin, C. M. Separation of active tubulin and microtubule-associated proteins by ultracentrifugation and isolation of a component causing the formation of microtubule bundles. Biochemistry, 23: 4173-4184, 1984.
6. Huang, A. B., Lin, C. M., and Hamel, E. Differential effects of magnesium on tubulin-nucleotide interactions. Biochim. Biophys. Acta, 832: 22-32, 1985.
7. Jiang, J. B., Hesson, D. P., Dusak, B. A., Dexter, D. L., Kang, G. J., and Hamel, E. Synthesis and Biological evaluation of 2-styrylquinazolin-4(3H)-ones, a new class of antimitotic anticancer agents which inhibit tubulin polymerization. J. Med. Chem., 33: 1721-1728, 1990.
8. Getahun, Z., Jurd, L., Chu, P. S., Lin, C. M., and Hamel, E. Synthesis of alkoxy-substituted diaryl compounds and correlation of ring separation with inhibition of tubulin polymerization: differential enhancement of inhibitory effects under suboptimal polymerization reaction conditions. J. Med. Chem., 35: 1058-1067, 1992.
9. Borisy, G. G. A rapid method for quantitative determination of microtubule protein using DEAE-cellulose filters. Anal. Biochem., 50: 373-385, 1972.
10. Hamel, E., and Lin, C. M. Guanosine 5′-O-(3-thiotriphosphate), a potent nucleotide inhibitor of microtubule assembly. J. Biol. Chem., 259: 11060-11069, 1984.
11. Bai, R., Paull, K. D., Herald, C. L., Malspeis, L., Pettit, G. R., and Hamel, E. Halichondrin B and homohalichondrin B., marine natural products binding in the vinca domain of tubulin: discover of tubulin-based mechanism of action by analysis of differential cytotoxicity data. J. Biol. Chem., 266: 15882-15889, 1991.
12. Hirata, V., and Uemura, D. Halichondrins-antitumor polyether macrolides from a marine sponge. Pure Appl. Chem., 58: 701-710, 1986.
13. Pettit, G. R., Herald, C. L., Boyd, M. R., Leet, J. E., Dufresne, C., Doubek, D. L., Schmidt, J. M., Cerny, R. L., Hooper, J. N. A., and Rutzler, K. C Isolation and structure of the cell growth inhibitory constituents from the Western Pacific marine sponge Axinella sp. J. Med. Chem., 34: 3339-3340, 1991.
14. Batra, J. K., Jurd, L., and Hamel, E. Structure-function studies with derivatives of 6-benzyl-1,3-benzodioxole, a new class of synthetic compounds which inhibit tubulin polymerization and mitosis. Mol. Pharmacol., 27:94-102, 1985.
15. Hamel, E., Ho, H. H., Kang, G-J., and Lin, C. M. Cornigerine, a potent antimitotic Colchicum alkaloid of unusual structure. Biochem. Pharmacol., 37: 2445-2449, 1988.
16. Lin, C. M., Ho, H. H., Pettit, G. R., and Hamel, E. Antimitotic natural products combretastatin A-4 and combretastatin A-2: studies on the mechanism of their inhibition of the binding of colchicine to tubulin. Biochemistry, 28: 6984-6991, 1989.
17. Saltarelli, D., and Pantaloni, D. Polymerization of the tubulin-colchicine complex and guanosine 5′-triphosphate hydrolysis. Biochemistry, 21:2996-3006, 1982.
18. Andreu, J. M., and Timasheff, S. N. Tubulin bound to colchicine forms polymers different from microtubules. Proc. Natl. Acad. Sci. USA, 79:6753-6756, 1982.
19. Muzaffar, A., Brossi, A., Lin, C. M., and Hamel, E. Antitubulin effects of derivatives of 3-demethylthiocoichicine, methylthio ethers of natural colchicinoids, and thioketones derived from thiocolchicine. Comparison with colchicinoids. J. Med. Chem., 33: 567-571, 1990.
20. Bai, R., Pettit, G. R., and Hamel, E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal: inhibition of tubulin polymerization mediated through the vinca alkaloid binding domain. Biochem. Pharmacol., 39: 1941-1949, 1990.
21. Duanmu, C., Shahrik, L., Ho, H. H., and Hamel, E. Tubulin-dependent hydrolysis of GTP as a screening test to identify new antimitotic agents: application to carbamates of aromatic amines. Cancer Res., 49: 1344-1348, 1989.
22. David-Pfeuty, T., Simon, C., and Pantaloni, D. Effect of antimitotic drugs on tubulin GTPase activity and self-assembly. J. Biol. Chem., 254: 11696-11702, 1979.
23. Lin, C. M., and Hamel, E. Effects of inhibitors of tubulin polymerization on GTP hydrolysis. J. Biol. Chem., 256:9242-9245, 1981.
24. Lin, C. M., Kang, G. J., Roach, M. C., Jiang, J. B., Hesson, D. P., Luduena, R. F., and Hamel, E. Investigation of the mechanism of the interaction of tubulin with derivatives of 2-styrylquinazolin-4(3H)one. Mol. Pharmacol., 40: 827-832, 1991.
25. Bai, R., Friedman, S. J., Pettit, G. R., and Hamel, E. Dolastatin 15, a potent antimitotic depsipeptide derived from Dolabella auricuLaria: interaction with tubulin and effects on cellular microtubules. Biochem. Pharmacol., in press, 1992.
26. Hamel, E. Interactions of tubulin with small ligands. In: J. Avila (ed.), Microtubule Proteins, pp. 89-191. Boca Raton, FL: CRC Press, 1990.